Tariq Musa 4

What Happened

Tariq Musa, a director of Guardant Health (GH), had 250 restricted stock units convert to common shares on July 15, 2026 (reported as an exercise/conversion of a derivative at $0). The Form 4 also reports a 250-share derivative disposition on July 15 (reported at $0). On July 16, 2026 he sold 116 shares in an open-market transaction at $163.29 per share, receiving $18,942.

Key Details

• Transaction types and dates:
  • 2026-07-15: Exercise/conversion of derivative — 250 shares acquired at $0.00 (reported code M).
  • 2026-07-15: Derivative disposition — 250 shares disposed at $0.00 (reported code M).
  • 2026-07-16: Open-market sale — 116 shares sold at $163.29 each for $18,942 (reported code S).
• Filing: Form 4 filed 2026-07-16 covering transactions on 7/15–7/16 (appears timely).
• Shares owned after the transactions: Not specified in the provided excerpt.
• Footnotes: Footnote F1 notes the RSU award was granted March 6, 2023 and vests over four years (25% vested March 15, 2024; remaining 75% vests monthly over the following three years). Footnote F2 is not applicable for RSUs.

Context

• The $0.00 acquisition price and the footnote indicate these were restricted stock units vesting (not a cash purchase). Converting RSUs into shares is common when awards vest; some filings also show derivative dispositions at $0 when tied to such conversions or settlement mechanics.
• The sale was an open-market transaction of a modest number of shares ($18.9k total) and does not by itself indicate insider sentiment. Retail investors typically view outright purchases as a stronger bullish signal than routine vesting and small sales.